JP Morgan Cazenove today reaffirms its overweight investment rating on Dechra Pharmaceuticals PLC (LON:DPH) and raised its price target to 3300p (from 3200p).
Pharmaceuticals and services group Clinigen upgraded its outlook on performance after reporting that profit nearly doubled, led by growth in its commercial medicines segment amid...
Copper and gold exploration company Chesterfield Resources said it expected to resume its drilling programme in approximately four weeks, when ground conditions had improved at...
Alberto Lavandeira, Chief Executive Officer, bought 30,000 shares in the company on the 21st February 2020 at a price of 176.00p. The Director now holds...
Robin Freestone, Chairman, bought 40,000 shares in the company on the 24th February 2020 at a price of 336.00p. The Director now holds 80,153 shares....
Oil and gas producer Jadestone Energy said production in 2019 had met expectations underpinned by a full-year of output at its Montara oil field offshore...